← Leaderboards
Shay Soker
Plureon Corporation
$4,976,348
Attributed
$8,118,925
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2006–18$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$8,118,925 · 8
By mechanism
R01$5,138,495 · 2
R33$1,157,668 · 1
R41$1,156,731 · 2
R21$651,031 · 2
R13$15,000 · 1
Top collaborators
- Ge Wang5 shared
- David B Agus4 shared
- Anthony Atala4 shared
- Graca Duarte Almeida-Porada2 shared
- Leonard P Miller1 shared
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroCellsTissuesBiomedical EngineeringIn VivoMolecularHistologyBlood VesselsScaffoldAffectEndothelial CellsAreaResolutionLaboratoriesTissue EngineeringComplexPublic Health RelevanceGrowthImageOrganResearch StudyStructureMeasurementLife
Grant awards (20)
Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine$385,924
R33 · FY2018 · CA · contact PI
Students and Young Investigators Activities at the 2017 TERMIS-Americas Meeting$15,000
R13 · FY2018 · EB · contact PI
Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine$385,924
R33 · FY2017 · CA · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$560,735
R01 · FY2016 · CA
Bioengineered Lung Tumor Organoids For Development Of Personalized Medicine$385,820
R33 · FY2016 · CA · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$577,096
R01 · FY2015 · CA
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$557,736
R01 · FY2014 · CA
Nondestructive, High Resolution Imaging Platform For Tissue Regeneration Research$186,198
R21 · FY2014 · EB · contact PI
Cord Blood Expansion Inside a Bioengineered Liver$113,190
R21 · FY2014 · HL
Optical Molecular Tomography for Regenerative Medicine$691,743
R01 · FY2013 · HL
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$590,138
R01 · FY2013 · CA
Nondestructive, High Resolution Imaging Platform For Tissue Regeneration Research$236,830
R21 · FY2013 · EB · contact PI
Cord Blood Expansion Inside a Bioengineered Liver$114,813
R21 · FY2013 · HL
Optical Molecular Tomography for Regenerative Medicine$4,892
R01 · FY2013 · HL
Optical Molecular Tomography for Regenerative Medicine$708,694
R01 · FY2012 · HL
ASC101 Enhancement of Regenerative Capacity of Amniotic Fluid-derived Stem Cells$156,754
R41 · FY2012 · HL
Optical Molecular Tomography for Regenerative Medicine$709,601
R01 · FY2011 · HL
Optical Molecular Tomography for Regenerative Medicine$737,860
R01 · FY2010 · HL
Cell therapy of diabetes using broad spectrum multipotent stem cells$499,992
R41 · FY2007 · DK · contact PI
Cell therapy of diabetes using broad spectrum multipotent stem cells$499,985
R41 · FY2006 · DK · contact PI